ARCHIVES

Gleevec Improves Survival Of CML In Accelerated Phase

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989

Biomedical Science Leadership is America’s Greatest Contribution, Benno Schmidt Says

August 14, 1987

Cancer Center To Get Recommended Funding, Restoration of 1990-91 Cuts, NCI Tells Directors

July 24, 1992

Longer List of DCPC Spending Plans $40 Mll Increase

December 10, 1993

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

April 13, 1984

NCI Programs: Institute Seeks White Papers On Technology

September 11, 1998